KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Return on Capital Employed (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Return on Capital Employed for 11 consecutive years, with 0.2% as the latest value for Q3 2024.

  • On a quarterly basis, Return on Capital Employed rose 102.0% to 0.2% in Q3 2024 year-over-year; TTM through Sep 2024 was 0.2%, a 102.0% increase, with the full-year FY2023 number at 0.24%, up 25.0% from a year prior.
  • Return on Capital Employed was 0.2% for Q3 2024 at Palvella Therapeutics, up from 0.15% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.2% in Q3 2024 to a low of 1.12% in Q1 2023.
  • A 5-year average of 0.42% and a median of 0.48% in 2021 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: tumbled -61bps in 2023, then skyrocketed 129bps in 2024.
  • Palvella Therapeutics' Return on Capital Employed stood at 0.38% in 2020, then fell by -24bps to 0.48% in 2021, then plummeted by -50bps to 0.72% in 2022, then surged by 47bps to 0.38% in 2023, then skyrocketed by 152bps to 0.2% in 2024.
  • Per Business Quant, the three most recent readings for PVLA's Return on Capital Employed are 0.2% (Q3 2024), 0.15% (Q2 2024), and 0.17% (Q1 2024).